Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial

REFERENCES

1. ↵
   1. Jabbari M,
   2. Cherry R,
   3. Lough JO,
   4. Daly DS,
   5. Kinnear DG,
   6. Goresky CA

   . Gastric antral vascular ectasia: The watermelon stomach. Gastroenterology 1984;87:1165-70.

   OpenUrlPubMed
2. ↵
   1. Dulai GS,
   2. Jensen DM,
   3. Kovacs TO,
   4. Gralnek IM,
   5. Jutabha R

   . Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy 2004;36:68-72.

   OpenUrlCrossRefPubMed
3. ↵
   1. Gyger G,
   2. Baron M

   . Gastrointestinal manifestations of scleroderma: Recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep 2012;14:22-9.

   OpenUrlCrossRefPubMed
4. ↵
   1. Burak KW,
   2. Lee SS,
   3. Beck PL

   . Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome. Gut 2001;49:866-72.

   OpenUrlFREE Full Text
5. ↵
   1. Jouanolle H,
   2. Bretagne JF,
   3. Ramee MP,
   4. Lancien G,
   5. Le Jean-Colin I,
   6. Heresbach D,
   7. et al.

   [Antral vascular ectasia and scleroderma. Endoscopic, radiologic and anatomopathologic aspects of an uncommon association. In French]. Gastroenterol Clin Biol 1989;13:217-21.

   OpenUrlPubMed
6. ↵
   1. Watson M,
   2. Hally RJ,
   3. McCue PA,
   4. Varga J,
   5. Jimenez SA

   . Gastric antral vascular ectasia (watermelon stomach) in patients with systemic sclerosis. Arthritis Rheum 1996;39:341-6.

   OpenUrlCrossRefPubMed
7. ↵
   1. Calamia KT,
   2. Scolapio JS,
   3. Viggiano TR

   . Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis. Clin Exp Rheumatol 2000;18:605-8.

   OpenUrlPubMed
8. ↵
   1. Marie I,
   2. Ducrotte P,
   3. Antonietti M,
   4. Herve S,
   5. Levesque H

   . Watermelon stomach in systemic sclerosis: Its incidence and management. Aliment Pharmacol Ther 2008;28:412-21.

   OpenUrlCrossRefPubMed
9. ↵
   1. Ingraham KM,
   2. O'Brien MS,
   3. Shenin M,
   4. Derk CT,
   5. Steen VD

   . Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. J Rheumatol 2010;37:603-7.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Ceribelli A,
    2. Cavazzana I,
    3. Airo P,
    4. Franceschini F

    . Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis. J Rheumatol 2010;37:1544.

    OpenUrlFREE Full Text
11. ↵
    1. Yamamoto M,
    2. Takahashi H,
    3. Akaike J,
    4. Suzuki C,
    5. Naishiro Y,
    6. Yamamoto H,
    7. et al.

    Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis. Scand J Rheumatol 2008;37:315-6.

    OpenUrlCrossRefPubMed
12. ↵
    1. Steen VD,
    2. Mayes MD,
    3. Merkel PA

    . Assessment of kidney involvement. Clin Exp Rheumatol 2003;21 Suppl 29:S29-31.

    OpenUrlPubMed
13. ↵
    1. Quintero E,
    2. Pique JM,
    3. Bombi JA,
    4. Bordas JM,
    5. Sentis J,
    6. Elena M,
    7. et al.

    Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology 1987;93:1054-61.

    OpenUrlPubMed
14. ↵
    1. Lorenzi AR,
    2. Johnson AH,
    3. Davies G,
    4. Gough A

    . Gastric antral vascular ectasia in systemic sclerosis: Complete resolution with methylprednisolone and cyclophosphamide. Ann Rheum Dis 2001;60:796-8.

    OpenUrlAbstract/FREE Full Text
15. ↵
    1. Schulz SW,
    2. O'Brien M,
    3. Maqsood M,
    4. Sandorfi N,
    5. Del Galdo F,
    6. Jimenez SA

    . Improvement of severe systemic sclerosis-associated gastric antral vascular ectasia following immunosuppressive treatment with intravenous cyclophosphamide. J Rheumatol 2009;36:1653-6.

    OpenUrlAbstract/FREE Full Text